Institutional Ownership Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX). We have compiled data on the 136 institutions that hold shares in the stock, with a total of 58.1 Million shares, which have been reported (via 13F filing form) to have a value of $2.43 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bvf Inc
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
19,751,284
shares
|
$828 Million
39.28% of portfolio
|
Q4 2024
Reduced 9.19%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
8,494,151
shares
|
$356 Million
35.64% of portfolio
|
Q4 2023
Added 4.32%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
3,343,643
shares
|
$140 Million
0.02% of portfolio
|
Q4 2024
Added 12.19%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
2,770,100
shares
|
$116 Million
2.15% of portfolio
|
Q3 2024
Added 0.0%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
2,186,866
shares
|
$91.6 Million
0.02% of portfolio
|
Q4 2024
Reduced 5.86%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,772,211
shares
|
$74.3 Million
3.59% of portfolio
|
Q4 2024
Added 90.26%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,674,664
shares
|
$70.2 Million
0.01% of portfolio
|
Q4 2024
Added 11.96%
|
|
|
Holocene Advisors, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,585,167
shares
|
$66.4 Million
0.29% of portfolio
|
Q3 2024
Reduced 2.53%
|
|
|
Westfield Capital Management CO LP
Boston, MA |
Feb 11, 2025 Q4 2024 |
1,311,619
shares
|
$55 Million
0.32% of portfolio
|
Q4 2024
Added 12.36%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Feb 13, 2025 Q4 2024 |
1,280,052
shares
|
$53.6 Million
0.16% of portfolio
|
Q4 2024
Added 13.25%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
1,245,299
shares
|
$52.2 Million
0.08% of portfolio
|
Q4 2024
Added 7.88%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
1,100,000
shares
|
$46.1 Million
0.36% of portfolio
|
Q4 2024
Added 120.0%
|
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
1,022,604
shares
|
$42.8 Million
0.02% of portfolio
|
Q4 2024
Added 2.45%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
894,005
shares
|
$37.5 Million
0.05% of portfolio
|
Q2 2023
New holding
|
|
|
Fred Alger Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
673,773
shares
|
$28.2 Million
0.18% of portfolio
|
Q4 2024
Added 1.08%
|
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Feb 14, 2025 Q4 2024 |
649,590
shares
|
$27.2 Million
0.6% of portfolio
|
Q4 2024
Added 0.45%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
595,581
shares
|
$25 Million
0.01% of portfolio
|
Q4 2024
Added 2.55%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Feb 14, 2025 Q4 2024 |
448,860
shares
|
$18.8 Million
0.03% of portfolio
|
Q4 2024
Added 9.69%
|
|
|
Finepoint Capital LP
Boston, MA |
Feb 13, 2025 Q4 2024 |
447,935
shares
|
$18.8 Million
2.02% of portfolio
|
Q4 2024
Added 15.2%
|
|
|
Camber Capital Management LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
441,000
shares
|
$18.5 Million
0.55% of portfolio
|
Q3 2024
Added 24.23%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
392,024
shares
|
$16.4 Million
0.0% of portfolio
|
Q2 2024
Reduced 3.98%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
346,617
shares
|
$14.5 Million
0.02% of portfolio
|
Q4 2024
Reduced 2.86%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
Feb 14, 2025 Q4 2024 |
346,111
shares
|
$14.5 Million
7.34% of portfolio
|
Q4 2024
Added 15.77%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
332,522
shares
|
$13.9 Million
0.83% of portfolio
|
Q4 2024
New holding
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
315,230
shares
|
$13.2 Million
2.51% of portfolio
|
Q4 2024
Reduced 9.69%
|